SeeThruEquity Issues Update on GEE Group Inc.

Jan 14, 2019

NEW YORK, NY / ACCESSWIRE / January 14, 2019 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has …

SeeThruEquity Issues Update on Nephros, Inc. (NEPH)

Dec 03, 2018

NEW YORK, NY / ACCESSWIRE / December 3, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has …

SeeThruEquity Issues Update on Innovus Pharmaceuticals with Target Price of $0.80

Nov 28, 2018

NEW YORK, NY / ACCESSWIRE / November 28, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has…

SeeThruEquity Initiates Coverage on Sector 5, Inc. (OTC: SFIV)

Nov 26, 2018

NEW YORK, NY / ACCESSWIRE / November 26, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has…

SeeThruEquity Initiates Coverage on RocketFuel Blockchain

Nov 13, 2018

NEW YORK, NY / ACCESSWIRE / November 13, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has…

SeeThruEquity Issues Update on Vitality Biopharma (VBIO) with Target Price of $3.50

Nov 07, 2018

NEW YORK, NY / ACCESSWIRE / November 7, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has …